                         SEQUENCE LISTING

<110>  Roche Diagnostics GmbH
       F. Hoffmann-La Roche AG
 
<120>  A method for labeling of aldehyde containing target molecules

<130>  P34235-WO

<150>  EP17166237
<151>  2017-04-12

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  formylglycine containing peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X at position 2 represents formylglycine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa at position 2 represents formylglycine

<400>  1

Leu Xaa Thr Pro Ser Arg Gly Ser Leu Phe Thr Gly Arg Lys 
1               5                   10                  


<210>  2
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  aldehyde tag sequence before formylglycine formation

<400>  2

Leu Cys Thr Pro Ser Arg Ala Ala Leu Leu Thr Gly Arg 
1               5                   10              


<210>  3
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  aldehyde tag after formation of formylglycine


<220>
<221>  X
<222>  (2)..(2)
<223>  X represents formylglycine

<220>
<221>  X
<222>  (2)..(2)
<223>  Xaa represents formylglycine

<400>  3

Leu Xaa Thr Pro Ser Arg Ala Ala Leu Leu Thr Gly Arg 
1               5                   10              


<210>  4
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  sequence analogous to aldehyde tag sequence

<400>  4

Leu Ala Thr Pro Ser Arg Ala Ala Leu Leu Thr Gly Arg 
1               5                   10              


